- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Kbi Biopharma
BioCentury | Mar 16, 2023
Management Tracks
Celsee’s Stark named Resolve CEO
Plus: New CEO for BioCina and updates from SeqOne and more
BioCentury | May 5, 2022
Management Tracks
Legault named Egle chairman
Plus Tom Hughes becomes chairman of Totus, and updates from Immunicum, Kbio and more
BioCentury | Nov 5, 2020
Management Tracks
Rosén joins Horizon as CSO and R&D head; plus moves at Boehringer, Dr. Reddy’s, Mylan and more
Karin Rosén joined Horizon Therapeutics plc (NASDAQ:HZNP) as CSO and EVP, research and development. She was SVP, U.S. medical affairs at GlaxoSmithKline plc (LSE:GSK; NYSE:GSK).
BioCentury | Apr 28, 2014
Emerging Company Profile
Aeglea: Old enzymes, new tricks
Aeglea's engineered human enzymes starve tumors
Items per page:
1 - 5 of 5